IP
70
-3
HCP
70
-4
STI
31
19
VNO
60
8
AIZ
78
2
NWSA
71
-2
MA
67
-5
PG
50
2
MPC
47
3
AIG
47
6
INTC
49
16
DRI
56
2
DIS
62
2
GILD
56
-4
CMS
58
-2
LNC
45
-4
AES
41
2
MU
32
-6
WDC
38
-3
HUM
48
2
IP
70
-3
HCP
70
-4
STI
31
19
VNO
60
8
AIZ
78
2
NWSA
71
-2
MA
67
-5
PG
50
2
MPC
47
3
AIG
47
6
INTC
49
16
DRI
56
2
DIS
62
2
GILD
56
-4
CMS
58
-2
LNC
45
-4
AES
41
2
MU
32
-6
WDC
38
-3
HUM
48
2
Financhill
Back

Macrogenics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
64

MGNX
Macrogenics

Last Price:
3.83
Seasonality Move:
20.1%
Sell
44

APLS
Apellis Pharmaceuticals

Last Price:
28.56
Seasonality Move:
20.78%
Buy
64
Macrogenics (MGNX) is a Buy

Is Macrogenics a Buy, Sell or Hold?

  • The current Macrogenics [MGNX] share price is $3.77. The Score for MGNX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • MGNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $28.23. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MGNX Stock Price Chart

What is Macrogenics's stock price today?

  • The Macrogenics share price today is $3.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $28.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

MGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 47.91 Sell
Chaikin Money Flow: -606424 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.58 - 4.2) Sell
Bollinger Bands (100): (3.26 - 4.52) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 46.19 Sell
Chaikin Money Flow: -1450356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.99 - 28.75) Buy
Bollinger Bands (100): (29.38 - 39.28) Sell

MGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.09 Sell
20-day SMA: 3.87 Sell
50-day SMA: 3.64 Buy
200-day SMA: 8.45 Sell
8-day EMA: 4.04 Sell
20-day EMA: 3.91 Sell
50-day EMA: 3.86 Sell
200-day EMA: 6.1 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.91 Sell
20-day SMA: 28.03 Buy
50-day SMA: 30.65 Sell
200-day SMA: 43.67 Sell
8-day EMA: 28.77 Sell
20-day EMA: 28.57 Sell
50-day EMA: 30.49 Sell
200-day EMA: 40.29 Sell

Macrogenics Earnings Growth & MGNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and a decrease next year of $1.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Macrogenics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):